Search
Search
Close this search box.

Map Shows Cannabis Contribution to States

This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day long leadership summit focused on retail, investment & policy across New York and North America. Tickets on-sale now – www.cannabisnewyork.live

The US Census Bureau has published a new map that reveals how much cannabis has contributed to state revenue across the country.

Described as an experimental data product, the map features tax collections from September 2023 to June 30, 2023.

The Bureau has stated that it provides quarterly estimates of state and local government tax revenue at a national level and detailed tax revenue data for individual states.

Whilst the majority of states do not have excise sales tax on cannabis products, a total of 5 state’s had this tax make up more than 1% of its state revenue.

Out of 21 tax collecting and reporting states, Oregon was the leading state in Q2 of 2023, with cannabis making up 3.19% of total tax revenue. The state saw a total of $42,257 in cannabis sales with $1,322,648 in total tax revenue. However, the map highlights that this was a 7.95% decrease from the previous quarter.

Second to the mark is Michigan at a total of 2.16% seeing $63,580 in cannabis sales and $2,939,137 in total tax revenue. This was a generous 8.53% increase from the previous quarter.

Thirdly, Illinois saw 2.04%, followed by Alaska at 1.32% and Colorado at 1.21%. Alaska saw the biggest increase from last quarter at 18.35%.

The Bureau stated: “Non‐response of the tax by any state known to be collecting cannabis excise taxes that is unable to be substituted with administrative data is left blank and marked with an “NA” in the table indicating the data was not available. Because there is no imputation of missing data, data in this experimental data product should not be used to estimate the total cannabis sales tax collected for the U.S..”

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

No Content Available

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?